PVT1 and acute myeloid leukemia: Indeed, 92% of AML cases carrying MYC amplifications as dmin, homogeneously staining region (hsr), or ring chromosomes (AML-amp) were characterized by expression of chimeric transcripts that frequently involved PVT1 as either a 5′ or 3′ partner, with PVT1 amplification.